A detailed history of Claro Advisors LLC transactions in Pfizer Inc stock. As of the latest transaction made, Claro Advisors LLC holds 41,762 shares of PFE stock, worth $1.15 Million. This represents 0.17% of its overall portfolio holdings.

Number of Shares
41,762
Previous 2,546 1540.3%
Holding current value
$1.15 Million
Previous $73,000 1554.79%
% of portfolio
0.17%
Previous 0.01%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

BUY
$27.7 - $31.39 $1.09 Million - $1.23 Million
39,216 Added 1540.3%
41,762 $1.21 Million
Q3 2024

Oct 17, 2024

SELL
$27.7 - $31.39 $1.06 Million - $1.2 Million
-38,337 Reduced 93.77%
2,546 $73,000
Q2 2024

Jul 31, 2024

BUY
$25.26 - $29.6 $34,227 - $40,108
1,355 Added 3.43%
40,883 $1.14 Million
Q1 2024

Apr 18, 2024

BUY
$25.89 - $29.73 $11,805 - $13,556
456 Added 1.17%
39,528 $1.1 Million
Q4 2023

Jan 22, 2024

SELL
$26.13 - $33.94 $384,215 - $499,053
-14,704 Reduced 27.34%
39,072 $1.12 Million
Q3 2023

Oct 10, 2023

SELL
$32.09 - $37.51 $159,872 - $186,874
-4,982 Reduced 8.48%
53,776 $1.78 Million
Q2 2023

Aug 08, 2023

SELL
$36.12 - $41.79 $35,253 - $40,787
-976 Reduced 1.63%
58,758 $2.16 Million
Q1 2023

Apr 17, 2023

BUY
$39.39 - $51.28 $67,475 - $87,842
1,713 Added 2.95%
59,734 $2.44 Million
Q4 2022

Feb 14, 2023

BUY
$41.75 - $54.5 $158,900 - $207,427
3,806 Added 7.02%
58,021 $2.97 Million
Q2 2022

Aug 12, 2022

BUY
$46.53 - $55.17 $4,513 - $5,351
97 Added 0.18%
54,215 $2.84 Million
Q4 2021

Feb 14, 2022

BUY
$41.32 - $61.25 $15,784 - $23,397
382 Added 0.71%
54,118 $3.2 Million
Q3 2021

Nov 15, 2021

BUY
$39.25 - $50.42 $23,314 - $29,949
594 Added 1.12%
53,736 $2.31 Million
Q2 2021

Aug 13, 2021

SELL
$35.91 - $40.68 $20,396 - $23,106
-568 Reduced 1.06%
53,142 $2.08 Million
Q1 2021

May 17, 2021

BUY
$33.49 - $37.77 $22,672 - $25,570
677 Added 1.28%
53,710 $1.95 Million
Q4 2020

Feb 12, 2021

SELL
$33.47 - $42.56 $210,124 - $267,191
-6,278 Reduced 10.58%
53,033 $1.95 Million
Q3 2020

Nov 16, 2020

BUY
$31.75 - $37.25 $25,654 - $30,098
808 Added 1.38%
59,311 $2.18 Million
Q2 2020

Aug 14, 2020

BUY
$30.12 - $36.54 $18,855 - $22,874
626 Added 1.08%
58,503 $1.91 Million
Q1 2020

May 15, 2020

BUY
$27.03 - $38.62 $27,138 - $38,774
1,004 Added 1.77%
57,877 $1.89 Million
Q4 2019

Feb 14, 2020

SELL
$32.92 - $37.36 $592 - $672
-18 Reduced 0.03%
56,873 $2.23 Million
Q3 2019

Oct 29, 2019

SELL
$32.49 - $42.13 $3,671 - $4,760
-113 Reduced 0.2%
56,891 $2.04 Million
Q2 2019

Jul 24, 2019

BUY
$36.98 - $41.52 $28,992 - $32,551
784 Added 1.39%
57,004 $2.47 Million
Q1 2019

May 10, 2019

BUY
$37.5 - $41.2 $251,100 - $275,875
6,696 Added 13.52%
56,220 $2.39 Million
Q4 2018

Feb 14, 2019

BUY
$38.47 - $43.86 $1.91 Million - $2.17 Million
49,524 New
49,524 $2.18 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $154B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Claro Advisors LLC Portfolio

Follow Claro Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Claro Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Claro Advisors LLC with notifications on news.